Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Effective Dose 90 of Remimazolam Loading Dose for Adequate Sedation in Patients Undergoing Orthopaedic Surgery Under Monitored Anesthetic Care

NCT05340335 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT05340335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Effective Dose 90 of Remimazolam Loading Dose for Adequate Sedation in Patients Undergoing Orthopaedic Surgery Under Monitored Anesthetic Care
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Completed
Start date
April 18, 2022
Completion date
May 2, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

orthopedic procedures, remimazolam, sedatives